MarketPulse — Real-Time Financial News & Market Analysis

Beyond Meat faces securities lawsuit over allegedly false asset valuations. Investors must take legal action by March 24, 2026 deadline.

Rosen Law Firm sues Sallie Mae for false disclosures on loan delinquencies. Investors have until February 17, 2026 deadline to join the class action lawsuit.

Ray Dalio warns geopolitical tensions could disrupt global capital flows and trigger a "capital war," threatening AI's $3 trillion funding needs and market stability.

Bath & Body Works faces securities lawsuit alleging false strategy claims. Investors who bought stock June 2024-November 2025 may qualify; March 16 deadline for lead plaintiff motions.

Freshworks stock tumbled 18.8% despite beating earnings expectations, as investors worried about slowing 14% projected revenue growth and broader tech sector weakness.

Ardent Health faces securities lawsuit alleging accounting fraud to overstate revenue through manipulated accounts receivable and delayed uncollectible recognition during 2024-2025.

Alphabet combines stable Google Search revenue with high-growth AI and cloud businesses, making it an attractive AI-focused investment with diverse revenue streams and strong fundamentals.

Rosen Law Firm sues Ultragenyx for securities fraud, alleging executives misrepresented drug efficacy. Investors who bought stock August 2023-December 2025 can claim damages by April 6, 2026 deadline.

Palantir's stock surged over 1,300% since its 2020 IPO, with a $10,000 investment growing to $142,820. AI adoption and sector expansion drive continued analyst optimism.

Rosen Law Firm initiates securities class action against Richtech Robotics for allegedly making false statements about a non-existent Microsoft partnership, causing shareholder losses.

CoreWeave, an AI infrastructure provider serving Meta, Microsoft, and OpenAI, is valued at 10x sales with $55.6 billion revenue backlog and projected 136% growth in 2026.

Law firm seeks lead plaintiffs for MCTA class action lawsuit over alleged undisclosed stock promotion scheme and social media fraud. Deadline: February 17, 2026.

Klarna faces securities lawsuit alleging it concealed loss reserve increases in its September 2025 IPO. Investors have until February 20 to join the class action.

AbbVie stock fell despite strong Q4 results and 10% revenue growth. Investors worry about Humira patent expiration, though new drugs Skyrizi and Rinvoq show promise.

Harvard Management invests $86.8M in Ethereum ETF, acquiring 3.87M shares. The move signals institutional adoption of crypto exposure despite recent market underperformance.

F5 faces class action lawsuit over undisclosed BIG-IP security breach. Stock plunged 10.9% after October disclosure; shareholders sought for litigation by February 17 deadline.

XLP outperforms FTXG with 11.12% annual return versus 6.87%, aided by lower fees (0.08% vs 0.60%) and broader diversification beyond food and beverages.

Walmart reaches $1 trillion valuation on 20% rally, but premium 45x earnings multiple raises sustainability concerns ahead of February earnings report.

Microsoft, The Trade Desk, and Nvidia trade below valuations reflecting their growth prospects, with analysts viewing them as undervalued despite strong financial performance.

Barrier Capital acquires $10M stake in real estate tech firm Compass, citing strong 24% revenue growth and attractive valuation metrics.